Effect of Some Drugs on Liver Fibrosis
Launched by SHERIEF ABD-ELSALAM · Dec 7, 2018
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how certain medications can affect liver fibrosis, which is a condition where the liver becomes scarred and damaged, often due to chronic hepatitis C. The trial is currently looking for participants to join, and it is open to individuals aged 73 and older, regardless of gender.
To be eligible for this study, you must have chronic hepatitis C, which means you have had this liver infection for a long time. However, if you have acute hepatitis (a sudden liver infection) or thalassemia (a blood disorder), you won't be able to participate. If you decide to join the trial, you can expect to receive treatment and have regular check-ups to monitor your liver health. This research is important because it may help improve treatment options for people with liver fibrosis in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • chronic hepatitis C
- Exclusion Criteria:
- • Acute hepatitis
- • Thalassemia
About Sherief Abd Elsalam
Sherief Abd-elsalam is a dedicated clinical trial sponsor with extensive expertise in advancing medical research and innovation. Committed to improving patient outcomes, Abd-elsalam oversees the design, implementation, and management of clinical trials across various therapeutic areas. With a strong focus on regulatory compliance and ethical standards, he fosters collaboration between research institutions, healthcare professionals, and regulatory bodies to ensure the successful progression of trials. Abd-elsalam's leadership is characterized by a commitment to scientific integrity and a passion for translating research findings into actionable healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tanta, , Egypt
Patients applied
Trial Officials
Gamal El-azab, Prof
Principal Investigator
Clinical pharmacy Department- Tanta University
Tarek Mostafa, Prof
Study Director
Cardiology Department- Tanta University
Gamal Badra, Prof
Study Chair
National Hepatology Institute - Egypt
Abeer El-Motwally, Msc
Study Chair
Clinical pharmacy Department-Tanta University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials